Chargement en cours...

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure

Prevention and treatment strategies for heart failure (HF) in diabetes have not been fully established, at least partly due to lack of recognition of a pathological link between the two and effective antidiabetic agents for HF. Recent cardiovascular (CV) outcomes trials demonstrated that treatment w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Tanaka, Atsushi, Node, Koichi
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968589/
https://ncbi.nlm.nih.gov/pubmed/29801492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0719-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!